176 related articles for article (PubMed ID: 1598874)
1. Effect of quinapril on blood pressure and heart rate in congestive heart failure.
Townend JN; West JN; Davies MK; Littler WA
Am J Cardiol; 1992 Jun; 69(19):1587-90. PubMed ID: 1598874
[TBL] [Abstract][Full Text] [Related]
2. Effect of angiotensin converting enzyme inhibition on plasma endothelin in congestive heart failure.
Townend J; Doran J; Jones S; Davies M
Int J Cardiol; 1994 Mar; 43(3):299-304. PubMed ID: 8181887
[TBL] [Abstract][Full Text] [Related]
3. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
Ding YA; Chang SM; Chou TC
J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
[TBL] [Abstract][Full Text] [Related]
5. Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
Kromer EP; Elsner D; Riegger GA
J Cardiovasc Pharmacol; 1990 Jul; 16(1):9-14. PubMed ID: 1696671
[TBL] [Abstract][Full Text] [Related]
6. [Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)].
Skvortsov AA; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Mareev VIu; Belenkov IuN
Ter Arkh; 2005; 77(8):34-43. PubMed ID: 16206603
[TBL] [Abstract][Full Text] [Related]
7. Effect of losartan on nocturnal blood pressure in patients with stroke: comparison with angiotensin converting enzyme inhibitor.
Okuguchi T; Osanai T; Fujiwara N; Kato T; Metoki N; Konta Y; Okumura K
Am J Hypertens; 2002 Nov; 15(11):998-1002. PubMed ID: 12441222
[TBL] [Abstract][Full Text] [Related]
8. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
Brown NJ; Agirbasli M; Vaughan DE
Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
[TBL] [Abstract][Full Text] [Related]
9. Quinapril in patients with congestive heart failure: controlled trial versus captopril.
Acanfora D; Furgi G; Trojano L; Picone C; Iannuzzi GL; Rossi M; Papa A; Rengo C; Rengo F
Am J Ther; 1997; 4(5-6):181-8. PubMed ID: 10423609
[TBL] [Abstract][Full Text] [Related]
10. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Plosker GL; Sorkin EM
Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective effects of quinapril after myocardial infarction in hypertensive rats.
Mori T; Nishimura H; Okabe M; Ueyama M; Kubota J; Kawamura K
Eur J Pharmacol; 1998 May; 348(2-3):229-34. PubMed ID: 9652338
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
Sedman AJ; Posvar E
Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
[TBL] [Abstract][Full Text] [Related]
13. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B
J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822
[TBL] [Abstract][Full Text] [Related]
14. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.
Lacourcière Y; Lefebvre J; Provencher P; Poirier L
Br J Clin Pharmacol; 1993 Feb; 35(2):121-7. PubMed ID: 8443029
[TBL] [Abstract][Full Text] [Related]
15. Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE inhibition in patients with mild to moderate congestive heart failure.
Pelliccia F; Borghi A; Ruggeri A; Cianfrocca C; Morgagni GL; Bugiardini R
Clin Cardiol; 1993 Aug; 16(8):607-12. PubMed ID: 8370193
[TBL] [Abstract][Full Text] [Related]
16. Effect of quinapril on the albumin excretion rate in patients with mild to moderate essential hypertension. Multicenter Study Group.
Larochelle P
Am J Hypertens; 1996 Jun; 9(6):551-9. PubMed ID: 8783779
[TBL] [Abstract][Full Text] [Related]
17. The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure.
Holt P; Najm J; Sowton E
Eur J Clin Pharmacol; 1986; 31(1):9-14. PubMed ID: 3023100
[TBL] [Abstract][Full Text] [Related]
18. An open, parallel group comparison of quinapril and captopril, when added to diuretic therapy, in the treatment of elderly patients with heart failure.
Beynon JH; Pathy MS
Curr Med Res Opin; 1997; 13(10):583-92. PubMed ID: 9327193
[TBL] [Abstract][Full Text] [Related]
19. Preliminary hemodynamic report of the efficacy and safety of quinapril in acute and chronic treatment of patients with congestive heart failure.
Banas JS
Angiology; 1989 Apr; 40(4 Pt 2):396-404. PubMed ID: 2705644
[TBL] [Abstract][Full Text] [Related]
20. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients?
Ruzicka M; Coletta E; Leenen FH
Am J Hypertens; 2007 Nov; 20(11):1202-8. PubMed ID: 17954368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
